Arbutus Biopharma Corporation(ABUS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABUS Arbutus Biopharma Corporation

休市中 09-11 16:00:00 EDT

5.12

+0.00

0.00%

盘后5.12

+0.00+0.07%

19:30 EDT

最高5.18	最低5.11	成交量185.00万
今开5.17	昨收5.12	日振幅1.27%
总市值10.08亿	流通市值6.30亿	总股本1.97亿
成交额948.91万	换手率1.50%	流通股本1.23亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABUS","market":"US","secType":"STK","nameCN":"Arbutus Biopharma Corporation","latestPrice":5.12,"timestamp":1789156800000,"preClose":5.12,"halted":0,"volume":1850049,"hourTrading":{"tag":"盘后","latestPrice":5.1236,"preClose":5.12,"latestTime":"19:30 EDT","volume":44555,"amount":228132.5547,"timestamp":1789169405255,"change":0.0036,"changeRate":0.000703,"amplitude":0.001953},"delay":0,"changeRate":0,"floatShares":123000000,"shares":196939679,"eps":0.789559,"marketStatus":"休市中","change":0,"latestTime":"09-11 16:00:00 EDT","open":5.17,"high":5.175,"low":5.11,"amount":9489146.8225023,"amplitude":0.012695,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.789559,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1184904000000,"exchange":"NASDAQ","adjPreClose":5.12,"preHourTrading":{"tag":"盘前","latestPrice":5.22,"preClose":5.12,"latestTime":"07:56 EDT","volume":36,"amount":187.094016,"timestamp":1789127789033,"change":0.1,"changeRate":0.019531,"amplitude":0.021484},"postHourTrading":{"tag":"盘后","latestPrice":5.1236,"preClose":5.12,"latestTime":"19:30 EDT","volume":44555,"amount":228132.5547,"timestamp":1789169405255,"change":0.0036,"changeRate":0.000703,"amplitude":0.001953},"volumeRatio":0.4267985182366269,"impliedVol":0.6912,"impliedVolPercentile":0.49},"requestUrl":"/m/hq/s/ABUS","defaultTab":"news","newsList":[{"id":"1172543358","title":"Arbutus启动2.3亿美元修改版“荷兰式拍卖”要约收购，回购价格区间设定为每股5.00至5.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172543358","media":"美股速递","labels":["shareholding","buyback","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172543358?lang=zh_cn&edition=full","pubTime":"2026-08-24 19:31","pubTimestamp":1787571115,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma Corporation今日宣布，正式启动一项总额高达2.3亿美元的修改版“荷兰式拍卖”要约收购计划，旨在回购公司普通股。荷兰式拍卖作为一种独特的定价机制，允许公司在预设的价格范围内收集股东出售意愿，并最终以能够完成全部回购数量的最低价格成交。分析人士指出，在当前市场环境下，Arbutus此举释放出积极的信号。随着要约收购的正式启动，市场也将密切关注该公司的股价反应以及股东的认购热情，以判断这一资本运作举措的最终成效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184420761","title":"Arbutus Biopharma公司：收购报价每股不低于5.00美元，不高于5.75美元，以现金支付","url":"https://stock-news.laohu8.com/highlight/detail?id=1184420761","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184420761?lang=zh_cn&edition=full","pubTime":"2026-08-21 19:31","pubTimestamp":1787311871,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma Corporation公布了一项收购提议，其每股收购价格设定在5.00美元至5.75美元之间，且全部以现金形式支付。这一报价区间明确了收购方愿意支付的价格范围——下限为每股5.00美元，上限则不超过每股5.75美元。具体而言，收购方给出的报价条件清晰而直接：每股价格不会低于5.00美元，同时也不会超越5.75美元的上限。股东们将有机会在这一既定范围内，根据自身判断做出相应决策。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159049869","title":"Arbutus Biopharma宣布要约收购预计于2026年8月24日启动，除非公司延期或终止","url":"https://stock-news.laohu8.com/highlight/detail?id=1159049869","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159049869?lang=zh_cn&edition=full","pubTime":"2026-08-21 19:31","pubTimestamp":1787311869,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma Corporation（以下简称\"公司\"）今日发布重要声明，其要约收购计划预计将于2026年8月24日前后正式启动。该计划一经推出，除非公司主动选择延期或终止，否则将按既定安排推进。\n这项备受市场关注的收购要约，其时间表的确定标志着公司战略布局进入关键阶段。从当前披露的信息来看，公司对该要约的推进持明确态度，但同时也保留了根据实际情况调整计划的灵活性。\n分析人士指出，此类要约收购的时间安排往往牵动多方利益，市场参与者正密切关注后续进展。随着8月24日这一时间节点的临近，相关各方的动向将成为影响事态发展的关键因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143407068","title":"Arbutus拟通过修改版“荷兰式拍卖”要约回购高达2.3亿美元普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1143407068","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143407068?lang=zh_cn&edition=full","pubTime":"2026-08-21 19:31","pubTimestamp":1787311869,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma公司今日宣布，计划以修改版“荷兰式拍卖”要约收购方式，回购总价值高达2.3亿美元的普通股。这一举措旨在优化资本结构，提升股东价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175800932","title":"Arbutus Biopharma与Genevant在加拿大提起诉讼，寻求对辉瑞/BioNTech的禁令及损害赔偿","url":"https://stock-news.laohu8.com/highlight/detail?id=1175800932","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175800932?lang=zh_cn&edition=full","pubTime":"2026-07-16 19:33","pubTimestamp":1784201632,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma Corporation与Genevant Sciences已在加拿大联邦法院提起诉讼，指控辉瑞与BioNTech SE侵犯其脂质纳米颗粒技术专利。该诉讼寻求法院颁布禁令，以阻止被告方继续使用相关专利技术，并要求其就侵权行为支付损害赔偿。诉状指出，辉瑞与BioNTech未经授权，在其新冠疫苗中使用了Arbutus和Genevant拥有的专有LNP递送技术。此次诉讼是Arbutus围绕其LNP知识产权发起的系列法律行动之一。案件的进展预计将受到生物技术及制药行业的密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999011175.SGD","SG9999013999.USD","LU1066053197.SGD","LU0170899867.USD","LU0306807586.USD","SG9999003800.SGD","LU1883839398.USD","IE0002270589.USD","LU1066051498.USD","IE00B19Z3B42.SGD","BK4535","LU0321505439.SGD","ABUS","IE00BLSP4239.USD","BK4533","IE00BLSP4452.SGD","BK4581","BK4548","LU0225771236.USD","SG9999001176.SGD","LU1894683264.USD","BK4568","LU0306806265.USD","LU0868494617.USD","BK4139","BK4551","BNTX","LU0225284248.USD","LU1023059063.AUD","SG9999001176.USD","IE000M9KFDE8.USD","BK4534","OZEM","PFE","IE00B19Z3581.USD","SG9999002232.USD","LU0058720904.USD","BK4592","SG9999002224.SGD","LU0321505868.SGD","LU0234572021.USD","LU2596442595.SGD","LU0985481810.HKD","IE00B3T34201.USD","BK4550","LU0122379950.USD","LU1894683348.USD","BK4585","LU1057294990.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","BK4599","BK4588","LU0289739699.SGD","BK4007","LU0456855351.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109842942","title":"Arbutus启动针对辉瑞和BioNTech的国际专利侵权诉讼，收到Moderna和解协议首付款并宣布计划向股东返还资本","url":"https://stock-news.laohu8.com/highlight/detail?id=1109842942","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109842942?lang=zh_cn&edition=full","pubTime":"2026-07-16 19:32","pubTimestamp":1784201554,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma已启动针对辉瑞和BioNTech的国际专利侵权诉讼程序，同时收到了与Moderna达成的和解协议项下的首笔付款，并宣布了向股东返还资本的意向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153533743","title":"Arbutus旗下Imdusiran获美国FDA快速通道资格 用于治疗慢性乙型肝炎","url":"https://stock-news.laohu8.com/highlight/detail?id=1153533743","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153533743?lang=zh_cn&edition=full","pubTime":"2026-04-15 19:31","pubTimestamp":1776252689,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma Corporation（股票代码：ABUS）宣布，其研发的乙肝治疗药物Imdusiran已获得美国食品药品监督管理局（FDA）授予的快速通道资格，将用于慢性乙型肝炎的治疗。\n这一重要监管里程碑有望加速该药物的审评进程，为患者提供更早获得创新疗法的可能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115450583","title":"Roivant Sciences董事会批准10亿美元股票回购计划，包含2025年6月授权的5亿美元额度","url":"https://stock-news.laohu8.com/highlight/detail?id=1115450583","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115450583?lang=zh_cn&edition=full","pubTime":"2026-03-04 05:17","pubTimestamp":1772572633,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd. (ROIV) 宣布，其董事会已正式批准一项总额高达10亿美元的股票回购计划。值得注意的是，此项授权中包含了该公司在2025年6月已批准的5亿美元回购额度。\n这一大规模的回购举措彰显了管理层对公司未来前景的坚定信心，并反映了其致力于通过资本回报为股东创造价值的承诺。通过回购并注销股票，公司有望提升每股收益，从而优化股东权益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROIV","BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121677386","title":"Roivant Sciences旗下Arbutus正评估于2026年第三季度向股东返还资本","url":"https://stock-news.laohu8.com/highlight/detail?id=1121677386","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121677386?lang=zh_cn&edition=full","pubTime":"2026-03-04 05:17","pubTimestamp":1772572631,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd. (ROIV) 旗下的生物制药公司 Arbutus Biopharma Corporation (ABUS) 目前正在积极评估一项资本返还计划。该计划旨在于2026日历年第三季度向公司股东返还资本。\n","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABUS","BK4007","BK4139","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518207799","title":"Arbutus Biopharma Corporation盘中异动 下午盘股价大跌5.14%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518207799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518207799?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:56","pubTimestamp":1741632962,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时56分，Arbutus Biopharma Corporation股票出现波动，股价快速下跌5.14%。截至发稿，该股报3.14美元/股，成交量62.6496万股，换手率0.33%，振幅5.56%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6137.21%、3854.01%、1014.73%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102560398a2db22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102560398a2db22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514354090","title":"Arbutus Biopharma Corporation盘中异动 早盘股价大涨8.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514354090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514354090?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493881,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Arbutus Biopharma Corporation股票出现异动，股价大幅上涨8.38%。截至发稿，该股报3.62美元/股，成交量3.106万股，换手率0.02%，振幅0.90%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Organovo Holdings, Inc.、Moleculin Biotech, Inc.、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为746.68%、510.41%、459.93%，振幅较大的相关个股有Organovo Holdings, Inc.、Igm Biosciences, Inc.、Pluri Inc.，振幅分别为8.13%、7.46%、7.15%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223121a253866c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223121a253866c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509789216","title":"Arbutus Biopharma Corporation盘中异动 临近收盘大幅下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509789216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509789216?lang=zh_cn&edition=full","pubTime":"2025-02-07 04:56","pubTimestamp":1738875416,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日04时56分，Arbutus Biopharma Corporation股票出现异动，股价急速跳水5.01%。截至发稿，该股报3.41美元/股，成交量97.927万股，换手率0.52%，振幅5.43%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Lipella Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为7126.59%、1780.58%、203.76%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为125.58%、77.86%、65.64%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207045656a23c1b08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207045656a23c1b08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509510232","title":"Arbutus Biopharma Corporation盘中异动 急速拉升5.06%报3.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509510232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509510232?lang=zh_cn&edition=full","pubTime":"2025-02-06 01:53","pubTimestamp":1738778039,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日01时53分，Arbutus Biopharma Corporation股票出现异动，股价大幅上涨5.06%。截至发稿，该股报3.53美元/股，成交量35.6686万股，换手率0.19%，振幅5.32%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为1.97%。其相关个股中，Transcode Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4523.61%、2218.27%、1673.58%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为122.81%、99.51%、59.58%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206015359987b9c9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206015359987b9c9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503215623","title":"Arbutus Biopharma Corporation盘中异动 早盘股价大涨5.03%报3.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503215623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503215623?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:21","pubTimestamp":1736954496,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日23时21分，Arbutus Biopharma Corporation股票出现波动，股价快速上涨5.03%。截至发稿，该股报3.34美元/股，成交量18.2586万股，换手率0.10%，振幅3.77%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为1.27%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152321369604c22f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152321369604c22f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503686403","title":"Arbutus Biopharma Corporation盘中异动 快速下挫5.04%报3.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503686403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503686403?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:15","pubTimestamp":1736885701,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时15分，Arbutus Biopharma Corporation股票出现波动，股价急速下跌5.04%。截至发稿，该股报3.18美元/股，成交量46.9732万股，换手率0.25%，振幅5.82%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体跌幅为1.25%。其相关个股中，Eterna Therapeutics Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Xortx Therapeutics Inc.涨幅较大，Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃，换手率分别为1085.40%、604.84%、421.94%，振幅较大的相关个股有Eterna Therapeutics Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Matinas Biopharma Holdings, Inc.，振幅分别为170.74%、146.24%、69.81%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115041501abaaf625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115041501abaaf625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502177405","title":"Arbutus Biopharma Corporation盘中异动 早盘股价大跌5.13%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502177405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502177405?lang=zh_cn&edition=full","pubTime":"2025-01-09 00:03","pubTimestamp":1736352189,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日00时03分，Arbutus Biopharma Corporation股票出现波动，股价急速跳水5.13%。截至发稿，该股报3.24美元/股，成交量7.6845万股，换手率0.04%，振幅4.11%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为3131.05%、578.54%、556.13%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为192.73%、139.44%、88.32%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109000309aba3605a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109000309aba3605a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501771349","title":"杰富瑞：Arbutus(ABUS.US)将受益于大型制药公司的禽流感疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2501771349","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501771349?lang=zh_cn&edition=full","pubTime":"2025-01-08 14:56","pubTimestamp":1736319369,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，杰富瑞认为，生物制药公司Arbutus Biopharma可能受益于Moderna和辉瑞/葛兰素史克/CureVac正在研发的H5N1禽流感疫苗。杰富瑞表示，Moderna，辉瑞及其合作伙伴BioNTech正被Arbutus起诉，称其在各自的新冠疫苗中使用的LNP技术侵犯了专利。杰富瑞补充称，如果这些制药公司在mRNA禽流感疫苗中使用与新冠疫苗相同的LNP成本，“特许权使用费可能会更高。”杰富瑞对Arbutus的股票评级为“买入”，目标价为7美元。截至周二美股收盘，Arbutus报每股3.41美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1234790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4127","BK1574","159646","BK1191","ABUS","JEF","BK4139","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501780576","title":"Arbutus Biopharma Corporation盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501780576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501780576?lang=zh_cn&edition=full","pubTime":"2025-01-08 01:26","pubTimestamp":1736270779,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日01时26分，Arbutus Biopharma Corporation股票出现波动，股价快速拉升5.20%。截至发稿，该股报3.44美元/股，成交量62.0125万股，换手率0.33%，振幅5.66%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为1.09%。其相关个股中，Hoth Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Conduit Pharmaceuticals Inc.涨幅较大，Hoth Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.、Immuneering Corporation较为活跃，换手率分别为4925.63%、394.14%、236.23%，振幅较大的相关个股有Hoth Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为287.95%、131.21%、87.05%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108012620985e318a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108012620985e318a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492589841","title":"Arbutus Biopharma Corporation盘中异动 股价大跌5.06%报3.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492589841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492589841?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:24","pubTimestamp":1734549849,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时24分，Arbutus Biopharma Corporation股票出现异动，股价快速跳水5.06%。截至发稿，该股报3.29美元/股，成交量38.9581万股，换手率0.21%，振幅4.91%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体跌幅为1.54%。其相关个股中，Polyrizon Ltd.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Cognition Therapeutics, Inc.涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3148.96%、647.96%、344.67%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、127.32%、105.17%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121903240995ea58f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121903240995ea58f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489311542","title":"Arbutus Biopharma Corporation盘中异动 急速拉升5.13%报3.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489311542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2489311542?lang=zh_cn&edition=full","pubTime":"2024-12-04 23:59","pubTimestamp":1733327958,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日23时59分，Arbutus Biopharma Corporation股票出现波动，股价大幅拉升5.13%。截至发稿，该股报3.59美元/股，成交量24.7831万股，换手率0.13%，振幅6.45%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Cyclerion Therapeutics, Inc.、Exicure, Inc.、Heron Therapeutics, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为2953.25%、243.12%、127.51%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 、Eterna Therapeutics Inc.，振幅分别为237.89%、61.32%、55.22%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120423591898e56125&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120423591898e56125&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arbutusbio.com","stockEarnings":[{"period":"1week","weight":-0.0058},{"period":"1month","weight":0.1155},{"period":"3month","weight":0.2019},{"period":"6month","weight":0.2019},{"period":"1year","weight":0.0449},{"period":"ytd","weight":0.0644}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arbutus Biopharma Corporation于2005年10月6日在不列颠哥伦比亚省注册成立。该公司是一家临床阶段的生物制药公司，利用其广泛的病毒学专业知识来识别和开发具有独特作用机制的新疗法，这些疗法可以潜在地结合起来，为慢性乙型肝炎病毒（HBV）感染患者提供功能性治愈。公司内部开发的专有化合物管线包括一种RNA治疗药物imdusiran（AB-729）和一种口服PD-L1抑制剂AB-101。Imdusiran已经产生了有意义的临床数据，证明了对表面抗原减少和HBV特异性免疫反应的重新唤醒的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.036052},{"month":2,"riseRate":0.818182,"avgChangeRate":0.072104},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.053764},{"month":4,"riseRate":0.636364,"avgChangeRate":-0.004947},{"month":5,"riseRate":0.454545,"avgChangeRate":0.047584},{"month":6,"riseRate":0.545455,"avgChangeRate":0.011849},{"month":7,"riseRate":0.454545,"avgChangeRate":0.133885},{"month":8,"riseRate":0.454545,"avgChangeRate":0.000176},{"month":9,"riseRate":0.583333,"avgChangeRate":0.066694},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.080232},{"month":11,"riseRate":0.545455,"avgChangeRate":0.037937},{"month":12,"riseRate":0.363636,"avgChangeRate":0.03682}],"exchange":"NASDAQ","name":"Arbutus Biopharma Corporation","nameEN":"Arbutus Biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arbutus Biopharma Corporation(ABUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arbutus Biopharma Corporation(ABUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arbutus Biopharma Corporation,ABUS,Arbutus Biopharma Corporation股票,Arbutus Biopharma Corporation股票老虎,Arbutus Biopharma Corporation股票老虎国际,Arbutus Biopharma Corporation行情,Arbutus Biopharma Corporation股票行情,Arbutus Biopharma Corporation股价,Arbutus Biopharma Corporation股市,Arbutus Biopharma Corporation股票价格,Arbutus Biopharma Corporation股票交易,Arbutus Biopharma Corporation股票购买,Arbutus Biopharma Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arbutus Biopharma Corporation(ABUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arbutus Biopharma Corporation(ABUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}